Release Date: 12/09/19 10:06 Summary: Rhinomed commence trading in the USA on the OTCQB market Price Sensitive: No Download Document 77.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%